BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 31822302)

  • 1. Screening of
    Baron SW; Ostrowsky BE; Nori P; Drory DY; Levi MH; Szymczak WA; Rinke ML; Southern WN
    Infect Control Hosp Epidemiol; 2020 Feb; 41(2):149-153. PubMed ID: 31822302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
    Alasmari F; Seiler SM; Hink T; Burnham CA; Dubberke ER
    Clin Infect Dis; 2014 Jul; 59(2):216-22. PubMed ID: 24755858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal screening for Clostridioides difficile in a tertiary hospital: risk factors for carriage and clinical disease.
    Meltzer E; Smollan G; Huppert A; Fluss R; Tal I; Gilboa M; Zilberman-Daniels T; Keller N; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2019 Sep; 25(9):1127-1132. PubMed ID: 30771530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
    Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
    Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.
    Zainul NH; Ma ZF; Besari A; Siti Asma H; Rahman RA; Collins DA; Hamid N; Riley TV; Lee YY
    Epidemiol Infect; 2017 Oct; 145(14):3012-3019. PubMed ID: 28891459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymptomatic Carriers Contribute to Nosocomial Clostridium difficile Infection: A Cohort Study of 4508 Patients.
    Blixt T; Gradel KO; Homann C; Seidelin JB; Schønning K; Lester A; Houlind J; Stangerup M; Gottlieb M; Knudsen JD
    Gastroenterology; 2017 Apr; 152(5):1031-1041.e2. PubMed ID: 28063955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole genome sequencing of toxigenic Clostridium difficile in asymptomatic carriers: insights into possible role in transmission.
    Halstead FD; Ravi A; Thomson N; Nuur M; Hughes K; Brailey M; Oppenheim BA
    J Hosp Infect; 2019 Jun; 102(2):125-134. PubMed ID: 30359648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.
    Baggs J; Yousey-Hindes K; Ashley ED; Meek J; Dumyati G; Cohen J; Wise ME; McDonald LC; Lessa FC
    Vaccine; 2015 Nov; 33(46):6241-9. PubMed ID: 26450660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural History of Clostridioides difficile Colonization and Infection Following New Acquisition of Carriage in Healthcare Settings: A Prospective Cohort Study.
    Curry SR; Hecker MT; O'Hagan J; Kutty PK; Alhmidi H; Ng-Wong YK; Cadnum JL; Jencson AL; Gonzalez-Orta M; Saldana C; Wilson BM; Donskey CJ
    Clin Infect Dis; 2023 Jul; 77(1):77-83. PubMed ID: 36905149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of a commercial PCR assay and a clinical prediction rule for detection of toxigenic Clostridium difficile in asymptomatic carriers.
    Donskey CJ; Sunkesula VC; Jencson AL; Stone ND; Gould CV; McDonald LC; Samore M; Mayer J; Pacheco S; Sambol S; Petrella L; Terry D; Gerding DN
    J Clin Microbiol; 2014 Jan; 52(1):315-8. PubMed ID: 24153132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of C. difficile Carriers Alone and as Part of a Bundle Approach for the Prevention of Clostridium difficile Infection (CDI): A Mathematical Model Based on Clinical Study Data.
    Grigoras CA; Zervou FN; Zacharioudakis IM; Siettos CI; Mylonakis E
    PLoS One; 2016; 11(6):e0156577. PubMed ID: 27258068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic and yet C. difficile-toxin positive? Prevalence and risk factors of carriers of toxigenic Clostridium difficile among geriatric in-patients.
    Nissle K; Kopf D; Rösler A
    BMC Geriatr; 2016 Nov; 16(1):185. PubMed ID: 27846818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonization of Toxigenic
    Mi H; Bao R; Xiao Y; Cui Y; Sun W; Shen Y; Shi Q; Chen X; Lin J; Hu B; Gao X
    Front Cell Infect Microbiol; 2020; 10():12. PubMed ID: 32083021
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and duration of asymptomatic Clostridium difficile carriage among healthy subjects in Pittsburgh, Pennsylvania.
    Galdys AL; Nelson JS; Shutt KA; Schlackman JL; Pakstis DL; Pasculle AW; Marsh JW; Harrison LH; Curry SR
    J Clin Microbiol; 2014 Jul; 52(7):2406-9. PubMed ID: 24759727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival.
    Behar L; Chadwick D; Dunne A; Jones CI; Proctor C; Rajkumar C; Sharratt P; Stanley P; Whiley A; Wilks M; Llewelyn MJ
    J Infect; 2017 Jul; 75(1):20-25. PubMed ID: 28435086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological model for Clostridium difficile transmission in healthcare settings.
    Lanzas C; Dubberke ER; Lu Z; Reske KA; Gröhn YT
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):553-61. PubMed ID: 21558767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.
    Zhang X; Wang X; Yang J; Liu X; Cai L; Zong Z
    BMC Infect Dis; 2016 Aug; 16():397. PubMed ID: 27506470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.